SCHEMBL1850792

SCHEMBL1850792

N#Cc1sc(NC(=O)C2CCCCC2)nc1-c1cc(F)cc(F)c1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 8/20 0.48
NPC1 O15118 7/20 0.48
ADORA3 P0DMS8 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.44
ACHE P22303 3/20 0.44
MAOA P21397 1/20 0.44
MAOB P27338 1/20 0.44
ADORA2A P29274 3/20 0.43
KDM4E B2RXH2 2/20 0.43
ADORA1 P30542 2/20 0.43
ALDH1A1 P00352 2/20 0.43
LMNA P02545 1/20 0.43
MAPT P10636 1/20 0.43
HPGD P15428 1/20 0.43
HTT P42858 1/20 0.43
MEN1 O00255 1/20 0.43
GFER P55789 1/20 0.43
KMT2A Q03164 1/20 0.43
CLK1 P49759 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1848647 0.91 ADORA3 (0.54) RAB9ANPC1ADORA3ACHEADORA2A
SCHEMBL1848588 0.89 ADORA3 (0.58) RAB9ANPC1ADORA3SMN1; SMN2ACHE
SCHEMBL1846481 0.89 ADORA2A (0.48) RAB9ANPC1ADORA3SMN1; SMN2ACHE
SCHEMBL1850214 0.88 ADORA3 (0.49) RAB9ANPC1ADORA3ACHEADORA2A
SCHEMBL1850215 0.88 ADORA3 (0.49) RAB9ANPC1ADORA3ACHEADORA2A
SCHEMBL1849219 0.88 ADORA3 (0.49) RAB9ANPC1ADORA3ACHEADORA2A
SCHEMBL1847530 0.88 ADORA3 (0.59) RAB9ANPC1ADORA3ACHEADORA2A
SCHEMBL1849827 0.87 ADORA2A (0.49) ADORA3ACHEADORA2AKDM4EADORA1
SCHEMBL1849984 0.86 GSK3B (0.45) RAB9ANPC1ADORA3SMN1; SMN2ACHE
SCHEMBL1847935 0.84 ADORA2A (0.62) RAB9ANPC1ADORA3SMN1; SMN2ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2197860-B1 NEW COMPOUNDS AS ADENOSINE A1 RECEPTOR ANTAGONISTS PALOBIOFARMA SL (ES) 2011-05-25 EP claimed
US-8410282-B2 Compounds as adenosine A1 receptor antagonists PALOBIOFARMA, S.L. (ES) 2013-04-02 US disclosed